DCT Contract Funds To Be 20 Percent less In FY 1986 Than In 1985; To Eliminate ‘Low Priority’ Contracts
In Brief: NCI Seeking Industry Support Again For Summer Program Congress Oks Smokeless Tobacco Bill
DCT Board Approves Phase 2/3 Studies Of LAK-IL-2
NCAB Approves Addition Of Two New Organ Systems
Clinical Education Program Phase Out Opposed By NCAB Committee
NCAB Votes To ‘Keep Alive’ Concept For Stage 2 Breast Cancer Fat Trial
Trending Stories
- Richard Pazdur left FDA to avoid being part of “the destruction of the American medical system”
- Pediatric cancer five-year survival rate has increased dramatically, AACR says in inaugural Pediatric Cancer Progress Report
- In first NCAB director’s report, Anthony Letai focuses on centralized grant review, budget outlook
- Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program
- Pazdur leaves FDA after 25-year career that shaped the agency’s oncology regulations
BIO calls for the end of “constant turmoil,” urges the administration to “right the ship” - Anthony Letai pledges to ensure stability for extramural and intramural cancer science









